Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Foreword
Author(s):
Simon Kennon
Added:
3 years ago
Article
Author(s):
Hassan MH Mohammed
,
Ahmed Farah
,
Bjoern Plicht
,
et al
Added:
1 year ago
Author(s):
Jan Balzer
,
Tobias Zeus
,
Verena Veulemans
,
et al
Added:
3 years ago
Percutaneous catheter-based structural heart disease procedures are a rapidly growing area of interventional cardiology, and represent a valuable option for cardiac patients with comorbidities who are ineligible for conventional surgery as well as demonstrating excellent outcomes.1,2 Catheter-based interventions include transcatheter aortic valve implantation (TAVI),3 percutaneous mitral valve …
View more
Author(s):
Vinayak Bapat
,
Simon Kennon
Added:
8 years ago
The Fortis Valve Mitral Valve Trnascatheter Heart Valve: CE Mark Trial Update
Simon Kennon and Vinayak Bapat at EuroPCR 2015
View more
Author(s):
Raquel del Valle-Fernández
,
Carlos E Ruiz
Added:
3 years ago
Mitral regurgitation (MR) is the second most prevalent valvular heart disease in developed countries and nearly one-third of the patients with isolated, native valve disease are diagnosed with significant MR, according to the Euro Heart Survey on Valvular Heart Disease.1
Mitral valve (MV) complex is a very complicated structure which consists of the mitral annulus (MA), valve leaflets, papillary…
View more
Author(s):
Chad A Kliger
Added:
3 years ago
Mitral regurgitation (MR) is a complex disorder requiring the understanding of mitral anatomy and pathophysiology. With the increasing patient population of mitral regurgitation, both functional and degenerative types, and our desire for less invasive treatment approaches, transcatheter mitral valve therapies (TMVT) have emerged. After more than a decade of advancements, development in TMVT still…
View more
Author(s):
Ozan M Demir
,
Mhairi Bolland
,
Jonathan Curio
,
et al
Added:
2 years ago
Author(s):
Amar Krishnaswamy
,
Emin Murat Tuzcu
,
Samir R Kapadia
Added:
3 years ago
Among patients undergoing surgical valve replacement, 1–5 % of patients with an aortic valve replacement (AVR) and 2–12 % with a mitral valve replacement (MVR) may develop paravalvular regurgitation or ‘leak’ (PVL).1–3 In the era of transcatheter aortic valve replacement (TAVR) with first-generation balloon expandable valves, up to 17 % of patients may be left with moderate or severe PVL, also…
View more
Author(s):
Magdalena Erlebach
,
Ruediger Lange
Added:
3 years ago
Patients with multivalvular disease (MVD) can present with a variety of valve pathologies and combinations, often requiring a complex treatment strategy. Both the Euro Heart Survey and the EURObservational Research Programme Valvular Heart Disease Registry (presented at the European Society of Cardiology [ESC] 2018 meeting) demonstrated that more than one-fifth of patients with native valve…
View more